MedTrace Logo

Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

NCT00805311 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-10-12

No results posted yet for this study

Summary

The aim of this study is to determine whether optimal medical treatment can postpone carotid endarterectomy.

Conditions

Interventions

PROCEDURE

Carotid Endarterectomy

CEA involves a neck incision and physical removal of the plaque from the inside of the artery

DRUG

atorvastatin, aspirin, losartan, amlodipine

aspirin 100 mg/day, atorvastatin 10 mg/day, losartan 50 mg/day, amlodipine 5 mg/day

Sponsors & Collaborators

  • Russian Cardiology Research and Production Center

    lead OTHER

Principal Investigators

  • Evgeniy Chazov, MD · Russian Cardiology Research and Production Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805311 on ClinicalTrials.gov